Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2
Authors
Keywords
laryngeal cancer, Hep-2/R, miR-26b, ATF2, cisplatin
Journal
Oncotarget
Volume 8, Issue 45, Pages -
Publisher
Impact Journals, LLC
Online
2017-09-09
DOI
10.18632/oncotarget.20784

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.